Cyclic Nucleotide Signaling and Phosphodiesterases
2027 FASEB Science Research Conference
June 3-5, 2027
Yours Truly DC, Washington, DC
Registration coming in November
Conference Summary
Dysregulated cyclic nucleotide signaling contributes to major human pathologies, including neurological, cardiovascular, substance use, respiratory, inflammatory, endocrine, metabolic, reproductive and infectious diseases. Accordingly, an enormous number of drugs have evolved from this field, attesting to its importance. Phosphodiesterase (PDE) inhibitors as a treatment for erectile dysfunction are well known, as are drugs that modulate cyclic AMP to treat psoriasis, COPD, cystic and pulmonary fibrosis and most recently, the hugely successful GLP-1 agonists. Yet we do not fully understand all the mechanisms involved in their actions.
This conference will highlight the most significant advances in our understanding of cyclic nucleotide signaling organization and its pathophysiological consequences. Investigators who study regulatory networks of cyclic nucleotide signaling in various tissues in health and disease will focus on the most recent knowledge on the structure and function of cyclic nucleotide effectors and degraders, such as PDEs, and their organization into macromolecular assemblies driven by scaffolds. A significant part of the program will be dedicated to the presentation of new therapeutic avenues arising from these discoveries.
Attendees will learn about:
- Recent breakthroughs in PDE structure and regulation
- Compartmentalized signaling within macromolecular complexes
- Structural and mechanistic insights into cyclic nucleotide effectors and degraders
- Cutting-edge technologies for visualizing signaling networks
- The development of novel therapeutic strategies targeting cyclic nucleotide pathways
Program topics include:
- Recent advances in understanding the players in cyclic nucleotide signal transduction in nanodomains of cells
- Spatiotemporal regulation of cyclic nucleotide signaling
- Novel mechanisms of cyclic nucleotide signaling in intracellular compartments
- Cyclic nucleotide regulation of substance addiction
- PDEs in neurological disorders
- Cyclic nucleotide regulation of cardiovascular function in health and disease
- Cyclic nucleotide signaling and PDEs in metabolism, tissue remodeling and fibrosis
Workshops:
Meet the Experts sessions designed to promote mentoring and discussion will focus on topics including: experimental design strategies for probing compartmentalized cAMP/cGMP signaling; best practices for pharmacological and genetic approaches to study PDE isoforms and signaling nanodomains; interpretation of cyclic nucleotide biosensor imaging and super-resolution methods; common pitfalls in PDE inhibitor studies; and translating basic cyclic nucleotide signaling discoveries into therapeutic opportunities.
A Career Development Workshop will feature representatives from academia, industry, and science administration describing their career paths and challenges, and giving advice to junior scientists on which skills to develop or which steps to take.
Important Dates
Early Registration and Early Abstract Deadlines: April 8, 2027
Early abstracts may be considered for short talks or posters
Abstract Edit & Submission/Registration Cancellation Deadlines: May 14, 2027
Abstracts submitted after the early deadline will be considered for posters
Regular Registration Deadline: May 27, 2027
Conference Venue
Yours Truly DC
1143 New Hampshire Avenue NW
Washington, D.C., DC 20037
The closest airports are:
Ronald Reagan Washington National Airport (DCA)
Dulles International Airport (IAD)
Keynote Speakers

Kjetil Wessel Andressen, PhD
Associate Professor
University of Oslo
Oslo, Norway
Manuela Zaccolo, MD, PhD, FRSB
Director, Burdon Sanderson Cardiac Sciences Centre
Professor of Cell Biology
University of Oxford
Oxford, UK

